5.31+0.44 (+9.10%) As of 11:31AM EDT. Market open. Volume 1,068,836 Avg. Volume 997,649
Finally a positive price increase, probably due to:
Atea Pharma's COVID-19 treatment fails to meet study goal; shares plunge The company is developing the oral drug, AT-527, in partnership with Roche (ROG.S) and both the companies are collaborating on multiple studies of the drug for the treatment of COVID-19.